Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

AstraZeneca's R&D expenditure as a percentage of revenue 2006-2019

This statistic shows AstraZeneca's research & development expenditure as a percentage of its total revenue from 2006 to 2019. In 2019, the company invested around 26 percent of its revenue into research and development. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2019

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2020

Region

Worldwide

Survey time period

2006 to 2019

Supplementary notes

All figures were calculated based on company data. Figures for 2006-2014 were taken from previous annual reports.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.